Centelles J J, Franco R, Bozal J
Department of Biochemistry and Physiology, Faculty of Chemistry, University of Barcelona, Spain.
J Neurosci Res. 1988 Feb;19(2):258-67. doi: 10.1002/jnr.490190212.
Rat brain adenosine deaminase (E.C. 3.5.4.4.) was purified 667-fold from the supernatant fraction by the following techniques: heat treatment (60 degrees C), fractionation with ammonium sulfate, column chromatography on DEAE-Sepharose, and preparative gel electrophoresis. The purified enzyme was homogeneous by the criterion of polyacrylamide disc gel electrophoresis and isoelectric focusing. Amino acid composition is given. The isoelectric point of the enzyme (5.2) was determined by isoelectric focusing on agarose. The apparent molecular weight was estimated to be 39,000 (Stokes Radius [Rs] = 27.3 A) using a calibrated Sephacryl S-300 column. The study of the influence of the temperature on the initial reaction rates allowed calculation of Ea (8.9 Kcal/mole) and delta H (5.0 Kcal/mole) values. The variation of V and Km with pH suggests the existence of a sulfhydryl group and an imidazole group in the enzyme-substrate complex. The enzyme had a Km (adenosine) of 4.5 X 10(-5) M and was inhibited by inosine, guanosine, adenine, and hypoxanthine but not by other intermediates of purine metabolism. None of the inhibitors were active as substrates. The enzyme was also inhibited by dimethyl sulfoxide and ethanol. Inhibition by ethanol can account partially for the CNS depressant effects of levels 3 and 4 of alcohol intoxication. A number of drugs having therapeutic uses such as sedative, anxiolytic, analgesic, and relaxant are modulators of the enzyme. Among these, lidoflazine, phenylbutazone, and chlordiazepoxide are the most potent as inhibitors (Ki 30, 54, and 83 microM, respectively), whereas medazepam is the most potent as activator (Ka 0.32 mM). Thus, it is concluded that some drugs that inhibit adenosine uptake also modulate adenosine deaminase activity. Besides, since the enzyme is located extracellularly [Franco et al, 1986], these drugs can modulate the physiological effects exerted by extracellular adenosine.
通过以下技术从大鼠脑上清液中纯化出了667倍的大鼠脑腺苷脱氨酶(E.C. 3.5.4.4.):热处理(60℃)、硫酸铵分级分离、DEAE-琼脂糖柱色谱以及制备性凝胶电泳。经聚丙烯酰胺圆盘凝胶电泳和等电聚焦标准判断,纯化后的酶是均一的。给出了氨基酸组成。通过在琼脂糖上进行等电聚焦测定了该酶的等电点(5.2)。使用校准的Sephacryl S-300柱估计该酶的表观分子量为39,000(斯托克斯半径[Rs]=27.3 Å)。研究温度对初始反应速率的影响,从而计算出了活化能(Ea,8.9千卡/摩尔)和焓变(ΔH,5.0千卡/摩尔)值。V和Km随pH值的变化表明酶-底物复合物中存在一个巯基和一个咪唑基。该酶的Km(腺苷)为4.5×10⁻⁵ M,并且受到肌苷、鸟苷、腺嘌呤和次黄嘌呤的抑制,但不受嘌呤代谢的其他中间产物抑制。这些抑制剂均不作为底物具有活性。该酶也受到二甲亚砜和乙醇的抑制。乙醇的抑制作用可以部分解释酒精中毒3级和4级时的中枢神经系统抑制作用。许多具有治疗用途的药物,如镇静剂、抗焦虑药、镇痛药和肌肉松弛剂,都是该酶的调节剂。其中,利多氟嗪、保泰松和氯氮䓬作为抑制剂最为有效(Ki分别为30、54和83 μM),而美达西泮作为激活剂最为有效(Ka为0.32 mM)。因此,可以得出结论,一些抑制腺苷摄取的药物也能调节腺苷脱氨酶的活性。此外,由于该酶位于细胞外[弗兰科等人,1986年],这些药物可以调节细胞外腺苷所发挥的生理作用。